The Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) have issued joint warning letters to 2 websites for illegally selling and distributing or dispensing schedule II stimulants, including amphetamine drug products marketed as Adderall.

The warning letters to and state that the websites are selling amphetamine drug products, including Adderall, that are misbranded and in violation of the Federal Food, Drug, and Cosmetic Act. Additionally, by failing to register the online pharmacies with the DEA, despite knowingly or intentionally advertising the sale of controlled substances, these websites are also in violation of the Ryan Haight Online Pharmacy Act.

“These letters are not only a warning to the companies that illegally sell prescription medications, but they also serve as a warning to consumers who have bought or have considered buying medications online without a legitimate prescription,” said DEA Administrator Anne Milgram. “Consumers cannot trust the safety or legitimacy of pills sold on unaccredited sites.”

In a press release, the Agency reinforced its commitment to stopping online operators illegally selling potentially harmful drug products to consumers. “These particular types of online pharmacies also undermine our efforts to help consumers safely purchase legitimate prescription medicines over the internet,” said FDA Commissioner Robert M. Califf, MD. “FDA will continue partnering with DEA in an effort to safeguard public health and protect consumers who need access to these important medicines.”


FDA and DEA warn online pharmacies illegally selling Adderall to consumers. News release. US Food and Drug Administration. Accessed April 12, 2022.